Indeed, similarly to what occur in patients carrying the p.E167K allele of TM6SF2, even rare mutations with large effect size in the Apolipoprotein B (APOB) gene, have been correlated with hypobetalipoproteinemia and a protection against cardiovascular complications, but with more severe liver injuries (15). This evidence concerns the gene APOB and hypobetalipoproteinemia.